Question 1

Am I eligible to participate in this trial based on my current health and medications?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) clinical trial (NCT06203002). Contact the study team or your healthcare provider for specific answers.

Question 2

How does LX9211 compare to my current pain management options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) clinical trial (NCT06203002). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the possible side effects of LX9211?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) clinical trial (NCT06203002). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit the clinic during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) clinical trial (NCT06203002). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) clinical trial (NCT06203002). Contact the study team or your healthcare provider for specific answers.

Question 6

Will my participation in this trial affect my current diabetes treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-ranging Study in Patients With Diabetic Peripheral Neuropathic Pain (DPNP) clinical trial (NCT06203002). Contact the study team or your healthcare provider for specific answers.

What this study is about